Physician profile
Anna Gray Kinney
NPI 1578164018
$3,867.22
in general payments reported to CMS, 2019-2025
28 companies · $1,621 in 2025
The $1,621 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $31.01 · 2024: $2,215 · 2025: $1,621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,037 · Travel and Lodging: $763 · Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,036.52 |
| Travel and Lodging | $762.70 |
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,226.21 | 2024 | Axonics |
| Janssen Biotech, INC. | $504.97 | 2023-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $440.38 | 2024-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $415.56 | 2024-2025 | |
| Tolmar, INC. | $236.26 | 2024-2025 | Jatenzo, Eligard |
| Antares Pharma, INC. | $155.51 | 2024-2025 | Xyosted |
| Coloplast Corp | $84.60 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $78.21 | 2024-2025 | Tlando, Trelstar |
| Merck Sharp & Dohme LLC | $59.86 | 2025 | Keytruda, Keytruda Qlex, Welireg |
| Urogen Pharma, INC. | $59.07 | 2025 | |
| Abbvie INC. | $56.57 | 2025 | |
| Boston Scientific Corporation | $52.41 | 2024-2025 | Axonics, Ams 700 |
| Endo USA, INC. | $48.61 | 2025 | Xiaflex, Aveed |
| Stryker Corporation | $48.24 | 2024 | Fluid Management System |
| Progenics Pharmaceuticals, INC. | $45.05 | 2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih Ab | $44.64 | 2025 | Lofric |
| Novo Nordisk INC | $38.96 | 2024-2025 | Rivfloza |
| Convatec INC. | $36.71 | 2025 | |
| Photocure INC | $35.00 | 2024 | Cysview |
| Laborie Medical Technologies Corp. | $34.02 | 2025 | |
| Teleflex LLC | $28.91 | 2025 | Urolift |
| Ethicon US, LLC | $28.83 | 2024 | Stratafix, Ethicon |
| Medtronic, INC. | $22.01 | 2024 | Interstim |
| Astellas Pharma US INC | $21.10 | 2025 | Xtandi |
| Sagent Pharmaceuticals | $20.11 | 2024 | Glydo |
| Bayer Healthcare Pharmaceuticals INC. | $16.06 | 2024 | |
| Abc Home Medical Supply, INC. | $15.00 | 2024 | |
| Azurity Pharmaceuticals, INC. | $14.36 | 2025 | Azmiro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Kinney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.